These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 23803082

  • 21. Association between three genetic variants in kallikrein 3 and prostate cancer risk.
    Ding WH, Ren KW, Yue C, Zou JG, Zuo L, Zhang LF, Bai Y, Okada A, Yasui T, Mi YY.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30413614
    [Abstract] [Full Text] [Related]

  • 22. Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population.
    Li P, Cao Q, Shao PF, Cai HZ, Zhou H, Chen JW, Qin C, Zhang ZD, Ju XB, Yin CJ.
    Asian J Androl; 2012 Nov 21; 14(6):864-9. PubMed ID: 23042446
    [Abstract] [Full Text] [Related]

  • 23. Association between single nucleotide polymorphisms on chromosome 17q and the risk of prostate cancer in a Chinese population.
    Zhou CH, Wang JY, Cao SY, Shi XH, Zhang YG, Liu M, Wang X, Huang J, Yang YG, Wei D, Yang Z.
    Chin J Cancer; 2011 Oct 21; 30(10):721-30. PubMed ID: 21959049
    [Abstract] [Full Text] [Related]

  • 24. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men.
    Liu F, Hsing AW, Wang X, Shao Q, Qi J, Ye Y, Wang Z, Chen H, Gao X, Wang G, Chu LW, Ding Q, OuYang J, Gao X, Huang Y, Chen Y, Gao YT, Zhang ZF, Rao J, Shi R, Wu Q, Wang M, Zhang Z, Zhang Y, Jiang H, Zheng J, Hu Y, Guo L, Lin X, Tao S, Jin G, Sun J, Lu D, Zheng SL, Sun Y, Mo Z, Xu J.
    Cancer Sci; 2011 Oct 21; 102(10):1916-20. PubMed ID: 21756274
    [Abstract] [Full Text] [Related]

  • 25. A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk.
    Tao L, Chen J, Zhou H, Qin C, Li P, Cao Q, Li J, Ju X, Zhu C, Wang M, Zhang Z, Shao P, Yin C.
    Prostate Cancer Prostatic Dis; 2013 Mar 21; 16(1):95-100. PubMed ID: 23045290
    [Abstract] [Full Text] [Related]

  • 26. Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs.
    Jiang H, Liu F, Wang Z, Na R, Zhang L, Wu Y, Zheng J, Lin X, Jiang D, Sun J, Zheng SL, Ding Q, Xu J.
    Prostate; 2013 Nov 21; 73(15):1651-9. PubMed ID: 23868750
    [Abstract] [Full Text] [Related]

  • 27. Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population: A case-control study.
    Zhang M, Wang Y, Wang C, You Z, Chen S, Kong Q, Xu B, Liu C, Chen M.
    Medicine (Baltimore); 2019 Dec 21; 98(52):e18523. PubMed ID: 31876746
    [Abstract] [Full Text] [Related]

  • 28. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
    Zhang Y, Li P, Xu A, Chen J, Ma C, Sakai A, Xie L, Wang L, Na Y, Kaku H, Xu P, Jin Z, Li X, Guo K, Shen H, Zheng S, Kumon H, Liu C, Huang P.
    Tumour Biol; 2016 May 21; 37(5):6653-9. PubMed ID: 26646562
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Polymorphisms of DNA repair-related genes with susceptibility and prognosis of prostate cancer.
    Zhang XJ, Liu P, Zhu F.
    Genet Mol Res; 2014 Jan 24; 13(2):4419-24. PubMed ID: 24615090
    [Abstract] [Full Text] [Related]

  • 33. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Shui IM, Lindström S, Kibel AS, Berndt SI, Campa D, Gerke T, Penney KL, Albanes D, Berg C, Bueno-de-Mesquita HB, Chanock S, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giles GG, Henderson B, Hoover R, Johansson M, Le Marchand L, Ma J, Navarro C, Overvad K, Schumacher FR, Severi G, Siddiq A, Stampfer M, Stevens VL, Travis RC, Trichopoulos D, Vineis P, Mucci LA, Yeager M, Giovannucci E, Kraft P.
    Eur Urol; 2014 Jun 24; 65(6):1069-75. PubMed ID: 24411283
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK, Sun J, Isaacs SD, Wiley KE, Yan G, Kim ST, Fedor H, DeMarzo AM, Epstein JI, Walsh PC, Partin AW, Trock B, Zheng SL, Xu J, Isaacs W.
    Prostate; 2009 Aug 01; 69(11):1195-205. PubMed ID: 19434657
    [Abstract] [Full Text] [Related]

  • 36. [Two single nucleotide polymorphisms on chromosome 3 and the risk of prostate cancer in Chinese men].
    Zhou L, Liu M, Huang J, Yang YG, Wei D, Shi XH, Zhang YG, Wang X, Zhou CH, Chen X, Yang Z, Wang JY.
    Zhonghua Nan Ke Xue; 2011 Aug 01; 17(8):682-7. PubMed ID: 21898988
    [Abstract] [Full Text] [Related]

  • 37. Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population.
    Oh JJ, Lee SJ, Hwang JY, Kim D, Lee SE, Hong SK, Ho JN, Yoon S, Sung J, Kim WJ, Byun SS.
    Oncotarget; 2017 Jul 04; 8(27):43934-43943. PubMed ID: 28380453
    [Abstract] [Full Text] [Related]

  • 38. The Cumulative Effect of Gene-Gene and Gene-Environment Interactions on the Risk of Prostate Cancer in Chinese Men.
    Liu M, Shi X, Yang F, Wang J, Xu Y, Wei D, Yang K, Zhang Y, Wang X, Liang S, Chen X, Sun L, Zhu X, Zhao C, Zhu L, Tang L, Zheng C, Yang Z.
    Int J Environ Res Public Health; 2016 Jan 27; 13(2):162. PubMed ID: 26828504
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association of HER-2 polymorphism with Japanese sporadic prostate cancer susceptibility.
    Yokomizo A, Koga H, Kinukawa N, Tsukamoto T, Hirao Y, Akaza H, Mori M, Naito S.
    Prostate; 2005 Jan 01; 62(1):49-53. PubMed ID: 15389808
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.